Government announces help for those with COPD buying inhalers

    Wednesday, 19 June 2024 07:00

    By Tonya Organ

    The change to open listing on the NL Prescription Drug Program reduces the administrative burden of prescribers by eliminating the special authorization process that had been in place.

    Government is expanding prescription coverage for long-acting muscarinic antagonist (LAMAs) inhalers, used in the treatment of Chronic Obstructive Pulmonary Disease. The change to open listing on the NL Prescription Drug Program reduces the administrative burden of prescribers by eliminating the special authorization process that had been in place. This will ensure NLPDP beneficiaries have timely access to these inhalers for the treatment of their COPD.

     

     

    To report an error, submit a news tip, or provide feedback, please e-mail news@bayfm.ca or call (709) 637-0183.

    More from Local News

     

     

     

    BayFM recognizes support from the following agencies:

                        

    Today's Weather

    • Corner Brook

      Sunny intervals

      High: 23°C | Low: 15°C

    • Deer Lake

      Sunny intervals

      High: 24°C | Low: 15°C

    Recently Played

    Podcasts

    • The Plain Truth

      The Plain Truth, September 18, 2025

      Host Paula Sheppard's guest this week is Allison Cains, Violence Prevention and Sara Project Coordinator

    • BayFM On-Demand

      Trash Talk Thursday

      Trash Talk Thursday , September 18, 2025

    • Qalipu Today

      Qalipu Today

      Qalipu Today , September 16 edition